References
- AMSTERDAM VAN, F. TH. M., OLIOSI, B., CORSI, M., RATTI, E., GAVIRAGHI, G. and TRIST, D. G., 1995, Receptor binding characteristics of the selective CCK-B antagonist GV150013. British Journal of Pharmacology, 116, 273.
- BOREL, A. G. and ABBOTT F. S., 1993, Metabolic profiling of clobazam, a 1,5-benzodiazepine, in rats. Drug Metabolism and Disposition, 21, 415–427.
- CHEN, W. U., DORLEY, J. M., RAMJIT, H. G., PITZENBERGER, S.M. and LIN, J. H., 1992, Physiological disposition and metabolism of L-365,260, a potent antagonist of brain cholecystokinin receptor, in laboratory animals. Drug Metabolism and Disposition, 20, 390–395.
- CORSI, M., DAL FORNO, G., AMSTERDAM VAN, F. TH. M., FERIANI A.,URSINI, A., RATTI, E., GAVIRAGHI G. and TRIST, D. G., 1995, The characterisation in functional assays of GV150013 : a novel CCK-B receptor antagonist. British Journal of Pharmacology, 114, 91.
- FINIZIA, G., DONATI, D., Ouosi, B., TRANQUILLINI, M. E. and URSINI, A., 1996, Synthesis and evaluation of novel 1,5-benzodiazepines as potent and selective CCK-B ligands. Effect of the substitution of the N-5 phenyl with alkyl groups. Bioorgank and Medicinal Chemistry Letters, 6, 2957–2962.
- KAJBAF, M., ROSSATO, P., BARNABY, J. R. and PELLEGATTI, M., 1998, Metabolism of a novel CCK-B antagonist in rat, dog and human liver microsomes. Xenobiotica, 22, 167–178.
- KAJBAF, M., ROSSATO, P., FERRARI, L., GROSSI, P. and PELLEGATTI, P., 1997, In vitro metabolism of GV150013X by using liver microsomes and liver tissue slices from different species. European Journal of Drug Metabolism and Pharmacokinetks, 22, 359–366.
- LOTTI, V. J. and CHANG R. S. L., 1989, A new potent and selective nonpeptide gastrin antagonist and brain CCK-B receptor ligand: L-365260. European Journal of Pharmacology, 162, 273–280.
- PENTASSUGLIA, G., BERTANI, B., DONATI, D. and URSINI, A., 1996, 1-Phenyl-4(1H)-quinazolinones and 2,3 -dihydro-1-pheny1-4(1H)-quinazolinones as potential cholecystokinin receptor ligands. Journal of Heterocyclic Chemistry, 33, 1163–1170.
- REGGIANI, A., GERRARD, P. A., MARAIA, G., MELOTTO, S., RATTI, E., GAVIRAGHI, G. and TRIST, D. G., 1995, Anxiolytic activity of GV150013, a new potent and selective cholecystokinin-B (CCK-B) antagonist. British Journal of Pharmacology, 114, 91.
- SAKAMOTO, C., WILLIAMS, J. A. and GOLDFINE, I. D., 1984, CCK receptors are structurally distinct from pancreas CCK receptors. Biochemical and Biophysical Research Communications, 124, 497–505.
- TRIST, D. G. and REGGIANI, A., 1996, Cholecystokinin-B (CCK-B) receptor antagonists and anxiety. Pharmacology Review and Communications, 8, 1–8.
- VOLZ, M., CHIRST, 0., KELLNER, H. M., KUCH, H., FEHLHABER, H. W., GANTZ, D., HAJDU, P. and CAVAGNA, F., 1979, Kinetics and metabolism of clobazam in animals and man. British Journal of Clinical Pharmacology, 7, 41S–50S.
- WILLIAMS, J. A., 1982, Cholecystokinin: a hormone and a neurotransmitter. Biomedical Research, 3, 107–121.